Cat. No. 1550
Chemical Name: 5-(4-Chlorophenyl)-1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole
Biological ActivityHighly selective cyclooxygenase-1 (COX-1) inhibitor (IC50 values are 0.009 and 6.3 μM for COX-1 and COX-2 respectively). Inhibits COX-1-derived platelet thromboxane B2, gastric PGE2 and dermal PDE2 production. Significantly reduces ovarian surface epithelial tumor growth in vivo. Orally active.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Certificate of Analysis / Safety Data Sheet
Smith et al (1998) Pharmacological analysis of cyclooxygenase-1 in inflammation. Pharmacology 95 13313.
Daikoku et al (2005) Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer. Cancer Res. 65 3735. PMID: 15867369.
Takeuchi et al (2005) COX inhibition and NSAID-induced gastric damage - roles in various pathogenic events. Curr.Top.Med.Chem. 5 475. PMID: 15974942.
If you know of a relevant citation for this product please let us know.
Keywords: SC 560, supplier, Cyclooxygenase, COX-1, inhibitors, Oxygenases, Oxidases, SC560
Find multiple products by catalog number
New Products in this Area
Cyclooxygenase-inhibiting nitric oxide donor
Win a Kindle
June 12 - 15, 2013
Booth Number: 213